☆
4.3
Meeting Abstract
Bromodomain inhibitor I-CBP112 breaks multidrug resistance conferred by overexpression of ABC transporters in cisplatin-resistant triple negative breast cancer
FEBS OPEN BIO (2022)
Rate this paper
The primary rating indicates the level of overall quality for the paper. Secondary ratings independently reflect strengths or weaknesses of the paper.
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation